154 related articles for article (PubMed ID: 3584490)
21. [Oncogenic osteomalacia in a 49-year-old female patient].
Ludwig J; Mechtersheimer G; Haberkorn U; Nawroth P; Schilling T; Kasperk C
Dtsch Med Wochenschr; 2005 Feb; 130(5):206-9. PubMed ID: 15678388
[TBL] [Abstract][Full Text] [Related]
22. Tumour-induced osteomalacia: a literature review and a case report.
Dadoniene J; Miglinas M; Miltiniene D; Vajauskas D; Seinin D; Butenas P; Kacergius T
World J Surg Oncol; 2016 Jan; 14(1):4. PubMed ID: 26744291
[TBL] [Abstract][Full Text] [Related]
23. Oncogenic osteomalacia.
Shenker Y; Grekin RJ
Isr J Med Sci; 1984 Aug; 20(8):739-41. PubMed ID: 6469602
[No Abstract] [Full Text] [Related]
24. [Osteomalacia and giant cell tumor: a rare case].
Sehli H; Daoud L; Ben Mbarek R; Ghorbel R; Ben Abdelghani K; Charfi H; Cheour I; Tarhouni L; Sellami S
Tunis Med; 2008 Sep; 86(9):836-8. PubMed ID: 19472787
[TBL] [Abstract][Full Text] [Related]
25. Effects of tumor-induced osteomalacia on the bone mineralization process.
Nawrot-Wawrzyniak K; Varga F; Nader A; Roschger P; Sieghart S; Zwettler E; Roetzer KM; Lang S; Weinkamer R; Klaushofer K; Fratzl-Zelman N
Calcif Tissue Int; 2009 Apr; 84(4):313-23. PubMed ID: 19219382
[TBL] [Abstract][Full Text] [Related]
26. Oncogenic vitamin D resistant hypophosphatemic osteomalacia (benign ossifying mesenchymal tumor of bone): case report.
Uchida H; Yokoyama S; Kashima K; Nakayama I; Shimizu K; Masumi S
Jpn J Clin Oncol; 1991 Jun; 21(3):218-26. PubMed ID: 1942553
[TBL] [Abstract][Full Text] [Related]
27. Development of tertiary hyperparathyroidism after phosphate supplementation in oncogenic osteomalacia.
Huang QL; Feig DS; Blackstein ME
J Endocrinol Invest; 2000 Apr; 23(4):263-7. PubMed ID: 10853715
[TBL] [Abstract][Full Text] [Related]
28. Octreotide scanning in the detection of a mesenchymal tumour in the pubic symphysis causing hypophosphataemic osteomalacia.
Moran M; Paul A
Int Orthop; 2002; 26(1):61-2. PubMed ID: 11954853
[TBL] [Abstract][Full Text] [Related]
29. Osteomalacia due to 1alpha,25-dihydroxycholecalciferol deficiency. Association with a giant cell tumor of bone.
Drezner MK; Feinglos MN
J Clin Invest; 1977 Nov; 60(5):1046-53. PubMed ID: 908749
[TBL] [Abstract][Full Text] [Related]
30. Osteomalacia-Inducing Tumors of the Brain: A Case Report, Review and a Hypothesis.
Fathalla H; Cusimano M; Di Ieva A; Karamchandani J; Fung R; Kovacs K
World Neurosurg; 2015 Jul; 84(1):189.e1-5. PubMed ID: 25746588
[TBL] [Abstract][Full Text] [Related]
31. Tumor-related osteomalacia followed after treatment by hyperparathyroidism.
Heylen A; Dasnoy D; Hustin J; Pochet JM
Rev Rhum Engl Ed; 1999 Jan; 66(1):53-7. PubMed ID: 10036701
[TBL] [Abstract][Full Text] [Related]
32. Tumour-induced osteomalacia.
Minisola S; Peacock M; Fukumoto S; Cipriani C; Pepe J; Tella SH; Collins MT
Nat Rev Dis Primers; 2017 Jul; 3():17044. PubMed ID: 28703220
[TBL] [Abstract][Full Text] [Related]
33. [Hypophosphatemic osteomalacia associated phosphaturic mesenchymal tumor of bone: report of a case].
Gong LH; Sun XQ; Xi Y; Ding Y; Huang XY
Zhonghua Bing Li Xue Za Zhi; 2013 Mar; 42(3):201-2. PubMed ID: 23769443
[No Abstract] [Full Text] [Related]
34. Tumor-induced hypophosphatemic osteomalacia associated with tertiary hyperparathyroidism: a case report.
Tartaglia F; Minisola S; Sgueglia M; Blasi S; Brunelli D; Degli Effetti E; Maturo A; Cola A; Custureri F; Campana FP
G Chir; 2006; 27(1-2):9-13. PubMed ID: 16608626
[TBL] [Abstract][Full Text] [Related]
35. A case of oncogenic osteomalacia detected by 111In-pentetreotide total body scan.
Casari S; Rossi V; Varenna M; Gasparini M; Parafioriti A; Failoni S; Sinigaglia L
Clin Exp Rheumatol; 2003; 21(4):493-6. PubMed ID: 12942704
[TBL] [Abstract][Full Text] [Related]
36. Case 3. Oncogenic osteomalacia associated with hemangiopericytoma localized by octreotide scan.
Auethavekiat P; Roberts JR; Biega TJ; Toney MO; Christensen RS; Belnap CM; Berenberg JL
J Clin Oncol; 2005 May; 23(15):3626-8. PubMed ID: 15908675
[No Abstract] [Full Text] [Related]
37. Osteomalacia by a mesenchymal-FGF23-producing tumour: Successful treatment with radiofrequency ablation. A case report.
Igney-Oertel A; Artunc F; Henes J; Hoffmann R; Clasen S
Joint Bone Spine; 2016 Oct; 83(5):603-4. PubMed ID: 27006265
[No Abstract] [Full Text] [Related]
38. Nasal hemangiopericytoma presenting with oncogenic osteomalasia: A case report and literature review.
Gökyer A; Sayın S; Küçükarda A; Çelik M; Güldiken S; Çiçin İ
Curr Probl Cancer; 2021 Jun; 45(3):100704. PubMed ID: 33446319
[TBL] [Abstract][Full Text] [Related]
39. Occult nasal sinus tumours causing oncogenic osteomalacia.
Kenealy H; Holdaway I; Grey A
Eur J Intern Med; 2008 Nov; 19(7):516-9. PubMed ID: 19013380
[TBL] [Abstract][Full Text] [Related]
40. Hypophosphatemic oncogenic osteomalacia: report of three new cases.
Papotti M; Foschini MP; Isaia G; Rizzi G; Betts CM; Eusebi V
Tumori; 1988 Oct; 74(5):599-607. PubMed ID: 3217995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
